You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

glucagon-like peptide-1 receptor agonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stroke, Stroke, Acute, Stroke, Ischemic Trial in Linyi, Hong Kong (Semaglutide)

Recruiting
  • Stroke
  • +3 more
  • Linyi, Shangdong, China
  • +1 more
Jun 24, 2023

Asthma Trial in Nashville (Semaglutide Pen Injector 2.4mg weekly, Placebo)

Not yet recruiting
  • Asthma
  • Semaglutide Pen Injector 2.4mg weekly
  • Placebo
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 22, 2022

Wolfram Syndrome Trial (Tirzepatide)

Not yet recruiting
  • Wolfram Syndrome
  • (no location specified)
Dec 12, 2022

Obesity Trial in Mansourah, Mansoura (Liraglutide)

Recruiting
  • Obesity
  • Mansourah, Dakhlia, Egypt
  • +1 more
Feb 24, 2022

Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)

Not yet recruiting
  • Kidney Transplant Recipients
  • Dapagliflozin 10 MG
  • Semaglutide, 1.0 mg/mL
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jul 6, 2023

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Parkinson's Disease Trial in Gainesville (Exenatide)

Completed
  • Parkinson's Disease
  • Gainesville, Florida
    Laboratory for Rehabilitation Neuroscience
Sep 14, 2022

Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

Recruiting
  • Diabetes Mellitus
  • Diabetic Kidney Disease
  • Sha Tin, Hong Kong
    Prince of Wales Hospital
Nov 8, 2022

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Second-line Therapies for Type 2 Diabetes and Moderate

Enrolling by invitation
  • Type 2 Diabetes
  • Cardiac Disease
  • Glucagon like peptide 1 receptor agonist
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic Rochester
Jan 26, 2022

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Alcohol Abuse, Alcohol Addiction, Alcohol Dependence Trial in Frederiksberg (Semaglutide Injectable Product, Placebo)

Recruiting
  • Alcohol Abuse
  • +3 more
  • Semaglutide Injectable Product
  • Placebo
  • Frederiksberg, Denmark
    Psychiatric Center Copenhagen, Frederiksberg Hospital
Jun 13, 2023

Ischemic Stroke Trial in Herlev (Byetta, Normosaline)

Recruiting
  • Ischemic Stroke
  • Herlev, Denmark
    Department of Neurology, Herlev-Gentofte Hospital
Nov 13, 2021

Metabolic Disturbance, Schizophrenia, Type 2 Diabetes Trial in Copenhagen (Semaglutide, 1.34 mg/mL, Semaglutide-)

Not yet recruiting
  • Metabolic Disturbance
  • +5 more
  • Semaglutide, 1.34 mg/mL
  • Semaglutide-placebo
  • Copenhagen, Denmark
    Psychiatric Center Copenhagen, Rigshospitalet
Jun 30, 2021

Mental Disorder, Metabolic Disturbance, Feasibility Trial (liraglutide 3 mg (Saxenda®) once-daily)

Not yet recruiting
  • Mental Disorder
  • +4 more
  • liraglutide 3 mg (Saxenda®) once-daily
  • (no location specified)
Jun 4, 2021

Type 2 Diabetes Trial in Copenhagen (Endurance exercise training, Semaglutide)

Recruiting
  • Type 2 Diabetes
  • Copenhagen, Denmark
    Xlab, Center for Healthy Aging, Department of Biomedical Science
Feb 8, 2021

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Not yet recruiting
  • Gastric Ultrasound
  • +2 more
  • Gastric Ultrasound Exam
  • (no location specified)
Aug 15, 2023

Alcohol Dependence, in Remission, Addiction, Alcohol Trial in Copenhagen (Exenatide 2 MG Injection, BD PosiFlush (saline))

Completed
  • Alcohol Dependence, in Remission
  • Addiction, Alcohol
  • Exenatide 2 MG Injection
  • BD PosiFlush (saline)
  • Copenhagen, Frederiksberg, Denmark
    Novavì ambulatorierne
Jun 3, 2021

Type 2 Diabetes, Peripheral Arterial Disease Trial in Napoli (Liraglutide, Control)

Recruiting
  • Type 2 Diabetes
  • Peripheral Arterial Disease
  • Napoli, Italy
    Unit of Endocrinology and Metabolic Diseases and Unit of Diabete
Jun 9, 2021

Effects of Glucagon-like-Peptide-1 Analogues on Sexuality

Recruiting
  • Sexual Desire
    • Basel, Switzerland
      University Hospital Basel, Endocrinology, Diabetes and Metabolis
    Nov 28, 2022

    Effects of GLP-1 Agonists on Gastric Volume

    Not yet recruiting
    • Diabetes
    • +3 more
    • Gastric Ultrasound
    • Charleston, South Carolina
      Medical University of South Carolina
    May 10, 2023

    A Pan-European Post-Authorisation Safety Study: Risk of

    Not yet recruiting
    • Pancreatic Cancer
    • Exenatide
    • Non-GLP-1 RA based glucose lowering drugs
    • (no location specified)
    Dec 21, 2022

    GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

    Recruiting
    • Diabetes Mellitus, Type 2
    • Myocardial Infarction
    • PCI
    • Naples, Italy
      Celestino Sardu
    Aug 31, 2023